Intravenous Vitamin C and Cancer
The use of intravenous vitamin C (ascorbate) is currently being studied by the National Institutes of Health (NIH) as an adjunctive therapy for cancer. Researchers from the NIH. The mechanism for its anti-tumor effect has been elucidated. When very high doses of Ascorbate are infused there is a pro-oxidant effect-releasing hydrogen peroxide. Normal cells can handle this whereas cancers can not. Therefore the oxidative stress caused by the ascorbate kills the cancer cells. Its is not as strong as conventional chemo but then there are less side effects as well. Think of it as "light chemo."